Provided by Tiger Fintech (Singapore) Pte. Ltd.

Organon & Co

9.76
+0.20002.09%
Post-market: 9.810.0500+0.51%19:59 EDT
Volume:3.89M
Turnover:38.38M
Market Cap:2.54B
PE:3.39
High:10.05
Open:9.60
Low:9.58
Close:9.56
Loading ...

Organon & Co. Navigates Growth Amidst Challenges

TIPRANKS
·
17 Feb

Organon Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
15 Feb

Organon & Is Maintained at Overweight by Barclays

Dow Jones
·
14 Feb

Bank of America Securities Reaffirms Their Sell Rating on Organon (OGN)

TIPRANKS
·
14 Feb

Morgan Stanley Keeps Their Hold Rating on Organon (OGN)

TIPRANKS
·
14 Feb

Organon price target lowered to $24 from $26 at Barclays

TIPRANKS
·
14 Feb

BUZZ-Organon rises on Q4 profit beat

Reuters
·
14 Feb

Stock Track | Organon & Co (OGN) Soars 8.98% on Strong Q4 Results and Optimistic 2025 Outlook

Stock Track
·
13 Feb

Organon & Co reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
13 Feb

Organon's Q4 Adjusted Earnings Rise, Revenue Declines; 2025 Sales Guidance Set

MT Newswires Live
·
13 Feb

Organon Expects 2025 Sales Of $6.125B-$6.325B Versus Consensus Of $6.471B

Benzinga
·
13 Feb

Organon & Co - Q4 2024 Net Income of $109 Million, $0.42 per Diluted Share

THOMSON REUTERS
·
13 Feb

Organon & Co - 2025 Revenue Guidance Range of $6.125 Billion - $6.325 Billion

THOMSON REUTERS
·
13 Feb

Organon & Co Q4 Total Revenue $1.592 Bln

THOMSON REUTERS
·
13 Feb

Organon & Co FY2025 Shr View $4.10, REV View $6.47 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
13 Feb

Organon Q4 2024 Adj EPS $0.90 Beats $0.87 Estimate, Sales $1.59B Inline

Benzinga
·
13 Feb

Organon (OGN) Q4 Earnings Report Preview: What To Look For

StockStory
·
12 Feb

Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Organon (OGN) and Inventiva (IVA)

TIPRANKS
·
12 Feb

Organon & Co : JP Morgan Cuts Target Price to $18 From $20

THOMSON REUTERS
·
27 Jan

With 79% ownership, Organon & Co. (NYSE:OGN) boasts of strong institutional backing

Simply Wall St.
·
24 Jan